AML restriction and item codes
Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.
PBS AML restriction and item codes
Contact details
PBS Complex Drugs Programs
Forms
Acute myeloid leukaemia - midostaurin - initial maintenance authority application form (PB253)
Acute myeloid leukaemia - oral azacitidine - dose escalation therapy continuing authority application form (PB355)
Services Australia website
Acute myeloid leukaemia
External websites
PBS schedule for:
FAQs from Service Officers
Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.
Item | Description |
1 | Can an initial approval for midostaurin be done over the phone? Yes. Induction and consolidation are done by telephone or electronic approval. The prescriber then completes an initial maintenance application in writing or electronically. |
2 | Can a patient switch from azacitidine injection to tablets as continuing treatment? No. The injection and tablets have different PBS criteria. Patients must meet the initial PBS criteria for the tablets. |
3 | Can dose escalation for azacitidine 300mg tablet be approved by phone? No. The prescriber must request a higher quantity of this PBS listing in writing or electronically. This is the only listing for the tablets that has a PBS application form. |
4 | How is the quantity for daunorubicin+cytarabine entered in OPA? This is an efficient funding of chemotherapy (EFC) listing. The quantity is entered in OPA based on the dose, in milligrams, of daunorubicin that is required. |
Expand all